NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled
NCT02352623 2016-05-26Quality of Life and Surgical Late Effects of Melanoma TreatmentHerlev HospitalCompleted435 enrolled